CAS 199673-74-0: Benzamide, 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]-,monohydrochloride

5-HT1F receptor agonist

LY 334370 Hydrochloride is a selective 5-HT1F receptor agonist, which is a chemical compound derived from advanced synthetic processes. As an agonist, it specifically targets the 5-HT1F receptor, a subtype of serotonin receptor that is implicated in neurovascular modulation. The selective activation of this receptor is thought to inhibit pro-inflammatory neuropeptide release and modulate pain pathways within the central nervous system. LY 334370 Hydrochloride is primarily utilized in the research and study of migraine mechanisms. Its ability to selectively bind to the 5-HT1F receptor makes it a valuable tool for investigating the therapeutic potential of receptor-specific agonists in the prophylaxis and management of migraines. Researchers leverage this compound to better understand the underlying pathophysiology of migraines and the role of serotonin receptors in their management, potentially guiding the development of targeted therapies with improved efficacy and reduced side effects compared to non-specific treatments.